Search clinical trials for: Belviq

Total 28 results

Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); New...

Terminated

Predictors of Lorcaserin-Induced Weight Loss

Overweight and Obesity

United States
Galderma Laboratorium GmbH

Completed

ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis

Actinic Keratoses

Germany
Glenn-Milo Santos
National Institute on Drug Abuse (NIDA)

Terminated

Treatment With Lorcaserin for Cocaine Use: The TLC Study (TLC)

Cocaine Use Disorder

United States
Beth Israel Deaconess Medical Center

Active, not recruiting

Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

Obesity | Weight Loss

United States
The Mind Research Network

Terminated

Mechanisms of Lorcaserin for Smoking Cessation

Smoking Cessation | Tobacco Use Disorder

United States
The Mind Research Network

Terminated

Laboratory Screening of Lorcaserin for Alcohol Use Disorder

Tobacco Smoking | Alcohol Use Disorder

United States
Eisai Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years

Obesity

United States
Mayo Clinic
National Institute on Drug Abuse (NIDA)

Terminated

Addressing Post Cessation Weight Gain

Smoking Cessation | Obesity

United States
University of North Carolina, Chapel Hill
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Columbia...

Terminated

MEtformin and Lorcaserin for WeighT Loss in Schizophrenia (MELT)

Overweight | Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

Lorcaserin for Cannabis Use Disorder

Cannabis Use Disorder

United States
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Completed

Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder

Opioid-Related Disorders | Opioid Dependence | Opioid Use | Opioid Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Lorcaserin in the Treatment of Cocaine Use Disorder

Cocaine-Related Disorders

United States
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Completed

Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder

Cocaine Use Disorder

United States
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Terminated

Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder

Opioid-Related Disorders | Cocaine-Related Disorders

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Gene-by-Stress Interactions in Intervention Studies Significance

Cardiovascular Diseases

United States
Scripps Whittier Diabetes Institute
Eisai Inc.

Completed

Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic

Obesity | Overweight | Weight Loss

United States
New York State Psychiatric Institute

Completed

Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder

Cannabis Use Disorder

United States
Eisai Inc.

Completed

Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age

Pharmacokinetics in Obese Adolescents

United States
Eisai Inc.
Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization

Completed

A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors (CAMELLIA-TIMI)

Obesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular Risk

United States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
Duke University
National Institute on Drug Abuse (NIDA)

Completed

Combination Nicotine Patch / Lorcaserin for Smoking Cessation (LorNic)

Nicotine Dependence

United States
Arena Pharmaceuticals

Completed

A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation

Smoking Cessation

United States
IlDong Pharmaceutical Co Ltd

Unknown

Belviq Tablet® Post Marketing Surveillance Protocol

Weight Loss
Eisai Inc.

Completed

A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy Participants

Healthy Participants

United States
Mayo Clinic

Completed

Lorcaserin for Preventing Weight Gain Among Smokers

Tobacco Use Disorder | Weight Gain

United States
Mayo Clinic

Completed

Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management

Overweight | Obese

United States
Midwest Biomedical Research Foundation

Unknown

Lorcaserin Intra Venous Cocaine Effects (LIVE)

Cocaine Use Disorders

United States
Southern California Institute for Research and...

Unknown

Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study

Weight Gain

United States
IlDong Pharmaceutical Co Ltd

Completed

Pharmacokinetic Study of Belviq in Adult Korean Volunteers

Healthy

Korea, Republic of

Search clinical trials for: Belviq

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations